[Form 4/A] KESTRA MEDICAL TECHNOLOGIES, LTD. Amended Insider Trading Activity

Rhea-AI Filing Summary

Amended Form 4 for Alfred J. Ford Jr. at Kestra Medical Technologies (KMTS). The filing retroactively reports the purchase of 20,000 common shares on 03/07/2025 at a price of $17.00 per share, acquired under the issuer's initial public offering reserved share program. Following this transaction, the reporting person beneficially owns 49,412 common shares in a direct capacity. The amendment states the shares were inadvertently omitted from prior filings. The form is signed by an attorney-in-fact for the reporting person.

Positive

• Corrective disclosure restores accuracy to Section 16 filings by reporting previously omitted shares
• Clear transaction details provided: 20,000 shares acquired on 03/07/2025 at $17.00 per share
• Beneficial ownership quantified after transaction: 49,412 common shares held directly

Negative

• Prior omission indicates earlier filings did not fully disclose this acquisition
• No explanation of why the omission occurred beyond describing it as inadvertent (no procedural detail)

Insights

Securities Compliance Analyst

TL;DR: Amendment corrects a prior omission, reporting a 20,000-share acquisition at $17 from the IPO reserved program.

The amendment documents a routine corrective disclosure under Section 16: 20,000 common shares were acquired on 03/07/2025 at $17.00 each and are now reported as part of the reporting person's direct holdings of 49,412 shares. The filing cites an inadvertent omission from earlier reports, which the amendment resolves. For compliance purposes this restores the public record of beneficial ownership and aligns the issuer's reserved-share allocations with the reporting person's Section 16 filings.

Corporate Governance Expert

TL;DR: Corrective filing improves transparency but contains no new compensatory or dilutive details.

The disclosure clarifies ownership but does not introduce new derivative instruments, option exercises, or material changes to board/officer status. It confirms the shares were linked to the IPO reserved share program rather than a separate compensation grant. The amendment reduces disclosure risk by reconciling the filing record with the issuer's allocation, supporting investor transparency without indicating material governance issues.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Ford Alfred J Jr

(Last) (First) (Middle)

C/O KESTRA MEDICAL TECHNOLOGIES, LTD.

3933 LAKE WASHINGTON BLVD NE, SUITE 200

(Street)

KIRKLAND WA 98033

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
KESTRA MEDICAL TECHNOLOGIES, LTD. [ KMTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)
07/21/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	03/07/2025		P		20,000(1)	A	$17	49,412	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported securities were purchased in connection with the Issuer's initial public offering reserved share program and were inadvertently omitted from the Reporting Person's prior filings.

	/s/ Traci S. Umberger as attorney-in-fact for Alfred J. Ford, Jr.	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Alfred J. Ford Jr. disclose on the Form 4/A for KMTS?

The amendment reports the acquisition of 20,000 common shares on 03/07/2025 at $17.00 per share under the issuer's IPO reserved share program.

How many KMTS shares does the reporting person own after the reported transaction?

The filing states the reporting person beneficially owns 49,412 common shares following the transaction, held directly.

Why was an amended Form 4 filed for KMTS (Form 4/A)?

The amendment explains the 20,000 shares were inadvertently omitted from prior filings and are now being reported to correct the record.

When was the acquisition of KMTS shares executed according to the filing?

The transaction date reported is 03/07/2025.

Who signed the amended Form 4 for Alfred J. Ford Jr.?

The form is signed by Traci S. Umberger as attorney-in-fact for Alfred J. Ford Jr., with a signature date of 09/15/2025.